Document

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Cartesian Therapeutics, Inc. Amended and Restated 2016 Incentive Award Plan of our report dated March 9, 2026, with respect to the consolidated financial statements of Cartesian Therapeutics, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2025, filed with the Securities and Exchange Commission.